Lawrence Kelly & Associates, Incorporated »

Regeneron Pharmaceuticals shares owned by Lawrence Kelly & Associates, Incorporated

Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Lawrence Kelly & Associates, Incorporated from 13F filings

Historical chart of Lawrence Kelly & Associates, Incorporated investment in Regeneron Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Regeneron Pharmaceuticals held by Lawrence Kelly & Associates, Incorporated consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regeneron Pharmaceuticals by Lawrence Kelly & Associates, Incorporated

Quarter filed Position value Share count Share price at filing
2023-09-30 $198k 240 822.96
2023-06-30 $285k 365 781.21
2023-03-31 $316k 385 821.67
2022-12-31 $278k 385 721.49
2022-09-30 $265k 385 688.31
2022-06-30 $228k 385 592.21
2022-03-31 $269k 385 698.70
2021-12-31 $243k 385 631.17
2021-09-30 $233k 385 605.19
2021-06-30 $215k 385 558.44
2021-03-31 $182k 385 472.73
2020-12-31 $170k 351 484.33
2020-09-30 $669k 1.2k 559.36
2020-06-30 $733k 1.2k 623.30
2020-03-31 $733k 1.5k 488.34
2019-12-31 $1.7M 4.5k 375.42
2019-09-30 $1.2M 4.5k 277.47
2019-06-30 $1.3M 4.1k 312.93
2019-03-31 $1.8M 4.3k 410.60
2018-12-31 $2.1M 5.7k 373.50
2018-09-30 $10M 26k 404.05
2018-06-30 $8.7M 25k 344.99
2018-03-31 $8.6M 25k 344.34
2017-12-31 $9.5M 25k 375.98
2017-09-30 $11M 25k 447.13
2017-06-30 $12M 25k 491.12
2017-03-31 $9.5M 25k 387.49
2016-12-31 $55k 150 366.67
2016-09-30 $60k 150 400.00
2016-06-30 $52k 150 346.67